Pancreatic Cancer Research

ResearcherHunan Institute of Science and TechnologyNo recent work listed

An Liu

Matched on ORCID iD 0000-0002-2160-1222; OpenAlex author ID A5101911999.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
3 (first author 3, last author 0)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
3
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 3

  1. MiRNA-3662 reverses the gemcitabine resistance in pancreatic cancer through regulating the tumor metabolism. First author DOI 10.1007/s00280-021-04289-z↗
  2. Twist promotes angiogenesis in pancreatic cancer by targeting miR-497/VEGFA axis. First author DOI 10.18632/oncotarget.8269↗
  3. [Emodin combined gemcitabine inhibited the growth of pancreatic cancer in vitro and in vivo and its mechanisms study]. First author PMID 22679728↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Jia Xu · 1 shared paper, 2021
  2. Dinghua Yang · 1 shared paper, 2016
  3. Jianhong Zhang · 1 shared paper, 2012

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.